Search

Your search keyword '"Naresh, Kikkeri N."' showing total 606 results
Start Over Author "Naresh, Kikkeri N."
606 results on '"Naresh, Kikkeri N."'

1. Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma

Author

Fortuna, Gliceida Galarza, Banerjee, Rahul, Savid-Frontera, Constanza, Song, Jinming, Morán-Segura, Carlos M., Nguyen, Jonathan V., Lekakis, Lazaros, Fernandez-Pol, Sebastian, Samraj, Annie N., Naresh, Kikkeri N., Vazquez-Martinez, Mariola, Baz, Rachid C., Spiegel, Jay Y., Mikkilineni, Lekha, Gubatan, John M., Sidana, Surbhi, de Menezes Silva Corraes, Andre, Kalariya, Nilesh M., Patel, Krina K., Shim, Kevin G., Fonseca, Rafael, Ferreri, Christopher, Voorhees, Peter M., Richard, Shambavi, Valdes, Cesar Rodriguez, Sireesha Asoori, Wolf, Jeffrey L., Cowan, Andrew J., Sborov, Douglas W., Locke, Frederick L., Lin, Yi, Wang, Yinghong, and Hansen, Doris K.

Published
2024
Full Text
View/download PDF

2. High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series

Author

Epperla, Narendranath, Zayac, Adam S., Landsburg, Daniel J., Bock, Allison M., Nowakowski, Grzegorz S., Ayers, Emily C., Girton, Mark, Hu, Marie, Beckman, Amy, Li, Shaoying, Medeiros, L. Jeffrey, Chang, Julie E., Kurt, Habibe, Sandoval-Sus, Jose, Ansari-Lari, Mohammad Ali, Kothari, Shalin K., Kress, Anna, Xu, Mina L., Torka, Pallawi, Sundaram, Suchitra, Smith, Stephen D., Naresh, Kikkeri N., Karimi, Yasmin, Bond, David A., Evens, Andrew M., Naik, Seema G., Kamdar, Manali, Haverkos, Bradley M., Karmali, Reem, Farooq, Umar, Vose, Julie M., Rubinstein, Paul, Chaudhry, Amina, and Olszewski, Adam J.

Published
2024
Full Text
View/download PDF

3. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D, Araujo, Iguaracyra Barreto de Oliveira, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John KC, Cheuk, Wah, Chng, Wee-Joo, Choi, John K, Chuang, Shih-Sung, Coupland, Sarah E, Czader, Magdalena, Dave, Sandeep S, de Jong, Daphne, Du, Ming-Qing, Elenitoba-Johnson, Kojo S, Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J, Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M, Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E, Kumar, Shaji, Lazar, Alexander J, Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S, Liu, Wei-Ping, Louissaint, Abner, Marcogliese, Andrea, Medeiros, L Jeffrey, Michal, Michael, Miranda, Roberto N, Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N, Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S Vincent, Rawstron, Andrew C, Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D, Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Subjects
Cancer, Hematologic Neoplasms, Humans, Lymphoma, World Health Organization, Clinical Sciences, Oncology and Carcinogenesis, Immunology
Abstract

We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.

Published
2022

4. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Author

Khoury, Joseph D, Solary, Eric, Abla, Oussama, Akkari, Yassmine, Alaggio, Rita, Apperley, Jane F, Bejar, Rafael, Berti, Emilio, Busque, Lambert, Chan, John KC, Chen, Weina, Chen, Xueyan, Chng, Wee-Joo, Choi, John K, Colmenero, Isabel, Coupland, Sarah E, Cross, Nicholas CP, De Jong, Daphne, Elghetany, M Tarek, Takahashi, Emiko, Emile, Jean-Francois, Ferry, Judith, Fogelstrand, Linda, Fontenay, Michaela, Germing, Ulrich, Gujral, Sumeet, Haferlach, Torsten, Harrison, Claire, Hodge, Jennelle C, Hu, Shimin, Jansen, Joop H, Kanagal-Shamanna, Rashmi, Kantarjian, Hagop M, Kratz, Christian P, Li, Xiao-Qiu, Lim, Megan S, Loeb, Keith, Loghavi, Sanam, Marcogliese, Andrea, Meshinchi, Soheil, Michaels, Phillip, Naresh, Kikkeri N, Natkunam, Yasodha, Nejati, Reza, Ott, German, Padron, Eric, Patel, Keyur P, Patkar, Nikhil, Picarsic, Jennifer, Platzbecker, Uwe, Roberts, Irene, Schuh, Anna, Sewell, William, Siebert, Reiner, Tembhare, Prashant, Tyner, Jeffrey, Verstovsek, Srdan, Wang, Wei, Wood, Brent, Xiao, Wenbin, Yeung, Cecilia, and Hochhaus, Andreas

Subjects
Genetics, Human Genome, 4.1 Discovery and preclinical testing of markers and technologies, Detection, screening and diagnosis, Hematologic Neoplasms, Histiocytosis, Humans, World Health Organization, Clinical Sciences, Oncology and Carcinogenesis, Immunology
Abstract

The upcoming 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database. This paper summarizes the new WHO classification scheme for myeloid and histiocytic/dendritic neoplasms and provides an overview of the principles and rationale underpinning changes from the prior edition. The definition and diagnosis of disease types continues to be based on multiple clinicopathologic parameters, but with refinement of diagnostic criteria and emphasis on therapeutically and/or prognostically actionable biomarkers. While a genetic basis for defining diseases is sought where possible, the classification strives to keep practical worldwide applicability in perspective. The result is an enhanced, contemporary, evidence-based classification of myeloid and histiocytic/dendritic neoplasms, rooted in molecular biology and an organizational structure that permits future scalability as new discoveries continue to inexorably inform future editions.

Published
2022

7. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D., de Oliveira Araujo, Iguaracyra Barreto, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John K. C., Cheuk, Wah, Chng, Wee-Joo, Choi, John K., Chuang, Shih-Sung, Coupland, Sarah E., Czader, Magdalena, Dave, Sandeep S., de Jong, Daphne, Di Napoli, Arianna, Du, Ming-Qing, Elenitoba-Johnson, Kojo S., Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J., Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M., Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E., Kumar, Shaji, Lazar, Alexander J., Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S., Liu, Wei-Ping, Louissaint, Jr, Abner, Marcogliese, Andrea, Medeiros, L. Jeffrey, Michal, Michael, Miranda, Roberto N., Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N., Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S. Vincent, Rawstron, Andrew C., Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R., Suzuki, Ritsuro, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D., Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Published
2023
Full Text
View/download PDF

10. A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Author

El-Sharkawi, Dima, Sud, Amit, Prodger, Catherine, Khwaja, Jahanzaib, Shotton, Rohan, Hanley, Brian, Peacock, Victoria, Peng, Ying Ying, Arasaretnam, Anita, Sharma, Sarkhara, Aldridge, Frances, Sharma, Bhupinder, Wotherspoon, Andrew, Cheung, Betty, De Lord, Corinne, Johnston, Rosalynd, Kassam, Shireen, Pettengel, Ruth, Linton, Kim, Greaves, Paul, Cook, Lucy, Naresh, Kikkeri N., Cwynarski, Kate, Eyre, Toby A., Chau, Ian, Cunningham, David, and Iyengar, Sunil

Published
2023
Full Text
View/download PDF

15. High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

Author

Zayac, Adam S., Landsburg, Daniel J., Hughes, Mitchell E., Bock, Allison M., Nowakowski, Grzegorz S., Ayers, Emily C., Girton, Mark, Hu, Marie, Beckman, Amy K., Li, Shaoying, Medeiros, L. Jeffrey, Chang, Julie E., Stepanovic, Adam, Kurt, Habibe, Sandoval-Sus, Jose, Ansari-Lari, M. Ali, Kothari, Shalin K., Kress, Anna, Xu, Mina L., Torka, Pallawi, Sundaram, Suchitra, Smith, Stephen D., Naresh, Kikkeri N., Karimi, Yasmin H., Epperla, Narendranath, Bond, David A., Farooq, Umar, Saad, Mahak, Evens, Andrew M., Pandya, Karan, Naik, Seema G., Kamdar, Manali, Haverkos, Bradley, Karmali, Reem, Oh, Timothy S., Vose, Julie M., Nutsch, Heather, Rubinstein, Paul G., Chaudhry, Amina, and Olszewski, Adam J.

Published
2023
Full Text
View/download PDF

17. Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

Author

Bewicke-Copley, Findlay, Korfi, Koorosh, Araf, Shamzah, Hodkinson, Brendan, Kumar, Emil, Cummin, Thomas, Ashton-Key, Margaret, Barrans, Sharon, van Hoppe, Suzan, Burton, Cathy, Elshiekh, Mohamed, Rule, Simon, Crosbie, Nicola, Clear, Andrew, Calaminici, Maria, Runge, Hendrik, Hills, Robert K., Scott, David W., Rimsza, Lisa M., Menon, Geetha, Sha, Chulin, Davies, John R., Nagano, Ai, Davies, Andrew, Painter, Daniel, Smith, Alexandra, Gribben, John, Naresh, Kikkeri N., Westhead, David R., Okosun, Jessica, Steele, Andrew, Hodson, Daniel J., Balasubramanian, Sriram, Johnson, Peter, Wang, Jun, and Fitzgibbon, Jude

Published
2023
Full Text
View/download PDF

18. Report of a Case With Clinical and Pathologic Features of Castleman Disease That Predates Castleman's Report by More Than 50 Years

Author

Pai, Sanjay A., Naresh, Kikkeri N., and Borges, Anita M.

Subjects
Diagnosis, Case studies, History, Lymphatic diseases -- Case studies -- Diagnosis -- History, Rare diseases -- Case studies -- Diagnosis -- History
Abstract

In 1954, Benjamin Castleman, MD, described, in the clinicopathologic exercises of the New England Journal of Medicine, the pathology of a lymph nodal condition, which he termed 'Hyperplasia of the [...], * Context.--In 1954, Benjamin Castleman, MD, described what was then believed to be a new entity in lymph node pathology. Initially labeled "Hyperplasia of the mediastinal node" and then "Localized mediastinal lymph node hyperplasia resembling thymoma," we now recognize the condition with the eponym "Castleman disease." We document a paper that describes the same condition, a half century before Castleman did. Objective.--To report the striking resemblance between Castleman disease and the lymph node reported in the paper published by Edwin R. LeCount, MD, titled "Lymphoma, a benign tumor representing a lymph gland in structure," published in Journal of Experimental Medicine in 1899. We also provide an overview of the remarkable achievements of LeCount. Design.--We compared the elucidation in the original paper by LeCount with the morphologic details in the papers published by Castleman et al. Material on the life of LeCount was compiled from the scientific literature, the Internet, and the files of the University of Chicago. Results.--LeCount's description and illustrations of the lymph node are uncannily similar to the onion-skinning and vascularity that Castleman documented. Conclusions.--LeCount deserves credit for his depiction of a hitherto-unreported entity. doi: 10.5858/arpa.2021-0205-HP

Published
2022
Full Text
View/download PDF

19. Understanding splenic B‐cell lymphoma/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions.

Author

Naresh, Kikkeri N.

Subjects
*HAIRY cell leukemia, *NOSOLOGY, *MUCOSA-associated lymphoid tissue lymphoma, *LYMPHOCYTIC leukemia, *CHRONIC leukemia
Abstract

Summary: The 5th edition of the WHO classification of haematolymphoid tumours (WHO‐HAEM5) introduced a new category, splenic B‐cell lymphoma/leukaemia with prominent nucleoli (SBLPN). The diagnostic entity B‐cell prolymphocytic leukaemia (B‐PLL) has been discontinued and the category of hairy cell leukaemia variant (HCLv) has been conceptually reframed. B‐PLL and HCLv diagnoses were uncommon. Overlap existed between B‐PLL and other indolent lymphomas like chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL). HCLv lacked consistent cytomorphological, immunophenotypic and genetic features. To address these issues, the WHO‐HAEM5 classification has introduced SBLPN to serve as a temporary holding ground for entities that do not neatly fit into the existing classification. Cases previously classified as CD5‐negative B‐PLL and HCLv fall under the SBLPN category. Some splenic marginal zone lymphoma and splenic diffuse red pulp small B‐cell lymphoma cases with higher number of medium or large nucleolated B cells would also be classified as SBLPN under the WHO‐HAEM5. This review explores the rationale for discontinuing B‐PLL and HCLv diagnoses. It then examines the concept of SBLPN, offers practical guidance for diagnosis and discusses future directions in classifying splenic B‐cell lymphomas. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma

Author

Trasanidis, Nikolaos, Katsarou, Alexia, Ponnusamy, Kanagaraju, Shen, Yao-An, Kostopoulos, Ioannis V., Bergonia, Bien, Keren, Keren, Reema, Paudel, Xiao, Xiaolin, Szydlo, Richard M., Sabbattini, Pierangela M.R., Roberts, Irene A.G., Auner, Holger W., Naresh, Kikkeri N., Chaidos, Aristeidis, Wang, Tian-Li, Magnani, Luca, Caputo, Valentina S., and Karadimitris, Anastasios

Published
2022
Full Text
View/download PDF

27. The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors – an overview and update

Author

Attygalle, Ayoma D., primary, Chan, John K. C., additional, Coupland, Sarah E., additional, Du, Ming-Qing, additional, Ferry, Judith A., additional, Jong, Daphne de, additional, Gratzinger, Dita, additional, Lim, Megan S., additional, Naresh, Kikkeri N., additional, Nicolae, Alina, additional, Ott, German, additional, Rosenwald, Andreas, additional, Schuh, Anna, additional, and Siebert, Reiner, additional

Published
2024
Full Text
View/download PDF

33. The fifth edition of the WHO classification of mature B‐cell neoplasms: open questions for research.

Author

Coupland, Sarah E, Du, Ming‐Qing, Ferry, Judith A, de Jong, Daphne, Khoury, Joseph D, Leoncini, Lorenzo, Naresh, Kikkeri N, Ott, German, Siebert, Reiner, and Xerri, Luc

Subjects
HAIRY cell leukemia, OPEN-ended questions, TUMORS, FOLLICULAR lymphoma, GENE expression
Abstract

The fifth edition of the World Health Organization Classification of Haematolymphoid Tumours (WHO‐HAEM5) is the product of an evidence‐based evolution of the revised fourth edition with wide multidisciplinary consultation. Nonetheless, while every classification incorporates scientific advances and aims to improve upon the prior version, medical knowledge remains incomplete and individual neoplasms may not be easily subclassified in a given scheme. Thus, optimal classification requires ongoing study, and there are certain aspects of some entities and subtypes that require further refinements. In this review, we highlight a selection of these challenging areas to prompt more research investigations. These include (1) a 'placeholder term' of splenic B‐cell lymphoma/leukaemia with prominent nucleoli (SBLPN) to accommodate many of the splenic lymphomas previously classified as hairy cell leukaemia variant and B‐prolymphocytic leukaemia, a clear new start to define their pathobiology; (2) how best to classify BCL2 rearrangement negative follicular lymphoma including those with BCL6 rearrangement, integrating the emerging new knowledge on various germinal centre B‐cell subsets; (3) what is the spectrum of non‐IG gene partners of MYC translocation in diffuse large B‐cell lymphoma/high‐grade B‐cell lymphoma and how they impact MYC expression and clinical outcome; how best to investigate this in a routine clinical setting; and (4) how best to define high‐grade B‐cell lymphoma not otherwise specified and high‐grade B‐cell lymphoma with 11q aberrations to distinguish them from their mimics and characterise their molecular pathogenetic mechanism. Addressing these questions would provide more robust evidence to better define these entities/subtypes, improve their diagnosis and/or prognostic stratification, leading to better patient care. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor‐T cell therapy.

Author

Yeung, Cecilia C. S., Woolston, David W., Wu, Vicky, Voutsinas, Jenna M., Basom, Ryan, Davis, Chris, Hirayama, Alexandre V., and Naresh, Kikkeri N.

Subjects
BONE marrow, CELLULAR therapy, HEMOPHAGOCYTIC lymphohistiocytosis, MACROPHAGE activation syndrome, ANTIGENS
Abstract

Background: Bone marrow (BM) assessment after CAR‐T cell immunotherapy infusion is not routinely performed to monitor adverse events such as cytopenias, hemophagocytic lymphohistiocytosis, or infections. Our institution has performed BM biopsies as part of CAR‐T cell treatment protocols, encompassing pre‐ and post‐treatment time points and during long‐term follow‐up. Methods: We conducted a systematic retrospective review of BM abnormalities observed in samples from 259 patients following CAR‐T cell immunotherapy. We correlated BM pathology findings with mortality, relapse/residual disease, and laboratory values. Results: At a median of 35.5 days post‐CAR‐T infusion, 25.5% showed severe marrow hypocellularity, and 6.2% showed serous atrophy, and peripheral blood cytopenias corroborated these observations. Marrow features associated with reduced disease burden post‐CAR‐T infusion include increased lymphocytes seen in 16 patients and an increase of macrophages or granulomatous response seen in 25 patients. However, a 100‐day landmark analysis also showed increased marrow histiocytes were associated with lower survival (median OS 6.0 vs. 21.4 months, p =.026), as was grade 2–3 marrow reticulin (18 patients) (median OS 12.5 vs. 24.2 months, p =.034). Conclusions: These data represent the first systematic observations of BM changes in patients receiving CAR‐T cell immunotherapy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

40. Classification of Haematolymphoid Neoplasms: A work in progress towards more precise disease definitions in the era of precision oncology.

Author

NARESH, KIKKERI N.

Subjects
TUMORS, HAIRY cell leukemia, NOSOLOGY, AUTOIMMUNE diseases, ONCOLOGY, DIFFUSE large B-cell lymphomas
Abstract

The article focuses on the importance of evidence-based disease classification for effective patient management and research, highlighting the WHO Classification of Tumours as a key system. Topics include the development of the Revised European–American Lymphoma (REAL) classification, the evolution of the WHO classification for haematolymphoid neoplasms, and the impact of genetic features on cancer diagnosis and treatment.

Published
2024
Full Text
View/download PDF

42. Mutations of ATM Confer a Risk of Inferior Survival in Patients with TP53-wild Type Mantle Cell Lymphoma

Author

Koff, Jean L., primary, Kositsky, Rachel, additional, Jaye, David L, additional, Churnetski, Michael C., additional, Baird, Katelin, additional, O'Leary, Colin B., additional, Flowers, Christopher R., additional, Leppa, Sirpa, additional, Karjalainen-Lindsberg, Marja-Liisa, additional, Li, Shaoying, additional, Xu, Jie, additional, Pedersen, Mette Ø, additional, Gang, Anne Ortved, additional, Naresh, Kikkeri N, additional, Leeman-Neill, Rebecca J, additional, Au Yeung, Kwok Him Rex, additional, Qureishi, Hina Naushad, additional, Iqbal, Javeed, additional, Chapman-Fredricks, Jennifer R, additional, McCall, Chad M., additional, Crump, Michael, additional, Chadburn, Amy, additional, Mulvey, Erin C., additional, Lossos, Izidore S., additional, Ondrejka, Sandra L., additional, Hsi, Eric D., additional, Louissaint, Abner, additional, Martin, Haley, additional, Tse, Eric, additional, Love, Cassandra, additional, Dave, Tushar, additional, Parker, Clay, additional, Ong, Choon Kiat, additional, Evans, Andrew G, additional, Behdad, Amir, additional, Yang, Lixin, additional, Reddy, Nishitha, additional, Arildsen, Mary Ann, additional, Juskevicius, Ridas, additional, Yan, Jiong, additional, Czader, Magdalena, additional, Evens, Andrew M., additional, Soliman, Dina Sameh, additional, Fedoriw, Yuri, additional, Dave, Sandeep S., additional, and Cohen, Jonathon B., additional

Published
2022
Full Text
View/download PDF

43. High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Central Nervous System (CNS) Involvement, Prophylaxis, and Recurrence Risk in a Multi-Institutional Series

Author

Epperla, Narendranath, primary, Zayac, Adam, additional, Landsburg, Daniel J., additional, Hughes, Mitchell, additional, Bock, Allison M., additional, Nowakowski, Grzegorz S., additional, Ayers, Emily C., additional, Girton, Mark, additional, Hu, Marie, additional, Beckman, Amy, additional, Li, Shaoying, additional, Medeiros, L. Jeffrey, additional, Chang, Julie E., additional, Stepanovic, Adam, additional, Kurt, Habibe, additional, Sandoval-Sus, Jose, additional, Ansari-Lari, M. Ali, additional, Kothari, Shalin K., additional, Kress, Anna, additional, Xu, Mina L, additional, Torka, Pallawi, additional, Sundaram, Suchitra, additional, Smith, Stephen D, additional, Naresh, Kikkeri N, additional, Karimi, Yasmin, additional, Bond, David A., additional, Farooq, Umar, additional, Saad, Mahak, additional, Evens, Andrew Matthew, additional, Pandya, Karan, additional, Naik, Seema G, additional, Kamdar, Manali, additional, Haverkos, Bradley M., additional, Karmali, Reem, additional, Oh, Timothy S, additional, Vose, Julie M., additional, Nutsch, Heather, additional, Rubinstein, Paul, additional, Chaudhry, Amina, additional, and Olszewski, Adam J., additional

Published
2022
Full Text
View/download PDF

44. Nodular Lymphocyte Predominant Hodgkin Lymphoma with Splenic Involvement Is Characterized By Inflamed Tumor Microenvironment, High Expression of Checkpoint Molecule Gene-Signature and Adverse Outcome

Author

Kalashnikov, Ilja, primary, Karjalainen-Lindsberg, Marja-Liisa, additional, Kovanen, Panu, additional, Dunkel, Johannes, additional, Pasanen, Annika, additional, Kositsky, Rachel, additional, Ondrejka, Sarah L., additional, Hsi, Eric D., additional, Evans, Andrew G, additional, Pedersen, Mette Ø, additional, Norgaard, Peter H., additional, Gang, Anne Ortved, additional, Czader, Magdalena, additional, Zhou, Jiehao, additional, Xu, Mina L, additional, Paulson, Nathan, additional, Juskevicius, Ridas, additional, Natkunam, Yasodha, additional, Louissaint, Abner, additional, Martin, Haley, additional, Thacker, Elizabeth, additional, Love, Cassandra, additional, Tian, Shari, additional, Ong, Choon Kiat, additional, Cheng, Chee Leong, additional, McCall, Chad M., additional, Koff, Jean L., additional, Younes, Sheren F., additional, Arildsen, Mary Ann, additional, Chapman-Fredricks, Jennifer R, additional, Amador, Catalina, additional, Fedoriw, Yuri, additional, Casulo, Carla, additional, Chadburn, Amy, additional, Sojitra, Payal, additional, Behdad, Amir, additional, Tse, Eric, additional, Naresh, Kikkeri N, additional, Yin, C. Cameron, additional, Goswami, Rashmi S., additional, Dave, Sandeep, additional, and Leppa, Sirpa, additional

Published
2022
Full Text
View/download PDF

45. Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site

Author

Chapman-Fredricks, Jennifer R, primary, Thakkar, Devang, additional, Alderuccio, Juan Pablo, additional, Naresh, Kikkeri N, additional, Ondrejka, Sarah L., additional, Hsi, Eric D., additional, Xu, Mina L, additional, Paulson, Nathan, additional, Koff, Jean L., additional, Jaye, David L, additional, Cohen, Jonathon B., additional, Ortved Gang, Anne, additional, Leeman-Neill, Rebecca J, additional, Dave, Tushar, additional, Happ, Lanie, additional, Love, Cassandra, additional, Zandi, Sasan, additional, Naushad, Hina, additional, Mason, Emily F, additional, Louissaint, Abner, additional, Martin, Haley, additional, Ong, Choon Kiat, additional, Pillai, Raju, additional, Pedersen, Mette Ø, additional, Yin, C. Cameron, additional, Choi, William, additional, Au-Yeung, Rex Kwok Him, additional, Karjalainen-Lindsberg, Marja-Liisa, additional, Chadburn, Amy, additional, Sarno, Vincent, additional, McKinney, Matthew, additional, Sojitra, Payal, additional, Evans, Andrew G, additional, Behdad, Amir, additional, Galvez, Carlos, additional, Cheng, Chee Leong, additional, Czader, Magdalena, additional, Yan, Jiong, additional, Dave, Sandeep S., additional, and Lossos, Izidore S., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results